Topically administered prednisolone and the antral phase of gastric secretion.
D000287:Administration, Topical; D000704:Analysis of Variance; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology*; D002712:Chlorides / Q000032:analysis; D004285:Dogs; D005260:Female; D005745:Gastric Acidity Determination; D005750:Gastric Juice / Q000378:metabolism*; D005753:Gastric Mucosa / Q000187:drug effects*; D006859:Hydrogen / Q000032:analysis; D008297:Male; D011188:Potassium / Q000032:analysis; D011239:Prednisolone; D011708:Pylorus / Q000187:drug effects*; D012964:Sodium / Q000032:analysis; D013268:Stimulation, Chemical; D014628:Vagotomy
D000893:Anti-Inflammatory Agents; D002712:Chlorides; D006859:Hydrogen; D012964:Sodium; D011239:Prednisolone; D011188:Potassium